Isolation and characterisation of a low molecular weight inhibitor (of chymotrypsin and human granulocytic elastase and cathepsin G) from leeches.

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 924384)

Published in Hoppe Seylers Z Physiol Chem on September 01, 1977

Authors

U Seemüller, M Meier, K Ohlsson, H P Müller, H Fritz

Articles by these authors

Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet (2001) 3.50

Reduction of background problems in nonradioactive northern and Southern blot analyses enables higher sensitivity than 32P-based hybridizations. Anal Biochem (1993) 2.93

Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome. Crit Care Med (1998) 2.85

Two different genes encode fibronectin binding proteins in Staphylococcus aureus. The complete nucleotide sequence and characterization of the second gene. Eur J Biochem (1991) 2.71

The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases. Eur J Biochem (1974) 2.65

Behavioral adjustments of African herbivores to predation risk by lions: spatiotemporal variations influence habitat use. Ecology (2009) 2.60

Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci U S A (1986) 2.49

Combined analgesia and local anesthesia to minimize pain during circumcision. Arch Pediatr Adolesc Med (2000) 2.16

Effect of human leukocyte enzymes on tracheal mucosa and its mucociliary activity. Rhinology (1979) 2.14

Comparison of transcutaneous and endtidal CO2-monitoring for rigid bronchoscopy during high-frequency jet ventilation. Acta Anaesthesiol Scand (2003) 2.02

The induction of pulmonary emphysema with human leukocyte elastase. Am Rev Respir Dis (1977) 1.95

The neutral proteases of human granulocytes. Isolation and partial characterization of two granulocyte collagenases. Eur J Biochem (1973) 1.92

[Perforation of the superior vena cava due to unrecognized stenosis. Case report of a lethal complication of central venous catheterization]. Anaesthesist (2001) 1.83

Haemophilus influenzae: comparison of respiratory tract isolates with genitourinary tract isolates. J Clin Microbiol (1982) 1.80

The receptor-destroying enzyme of influenza C virus is neuraminate-O-acetylesterase. EMBO J (1985) 1.76

Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. Arzneimittelforschung (1983) 1.74

Role of fiberoptic bronchoscopy in conjunction with the use of double-lumen tubes for thoracic anesthesia: a prospective study. Anesthesiology (1998) 1.73

Transcription of Staphylococcus aureus fibronectin binding protein genes is negatively regulated by agr and an agr-independent mechanism. J Bacteriol (1997) 1.72

Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest (1999) 1.72

Interaction between human or dog leucocyte proteases and plasma protease inhibitors. Scand J Clin Lab Invest (1971) 1.71

Nomenclature and classification of the proteins homologous with the cysteine-proteinase inhibitor chicken cystatin. Biochem J (1986) 1.71

Protein GRAB of streptococcus pyogenes regulates proteolysis at the bacterial surface by binding alpha2-macroglobulin. J Biol Chem (1999) 1.67

The disappearance of enzyme-inhibitor complexes from the circulation of man. Clin Sci Mol Med (1976) 1.57

Simian virus 40 minichromosomes as targets for retroviral integration in vivo. Proc Natl Acad Sci U S A (1992) 1.53

Neutral leucocyte proteases and elastase inhibited by plasma alpha 1 -antitrypsin. Scand J Clin Lab Invest (1971) 1.50

Renal artery aneurysm: surgical indications and results. Eur J Vasc Surg (1992) 1.49

The acid-stable proteinase inhibitor of human mucous secretions (HUSI-I, antileukoprotease). Complete amino acid sequence as revealed by protein and cDNA sequencing and structural homology to whey proteins and Red Sea turtle proteinase inhibitor. FEBS Lett (1986) 1.47

Screening for bacteriuria with a tet paper for glucose. JAMA (1968) 1.45

Structure of the elastase-cathepsin G inhibitor of the leech Hirudo medicinalis. Hoppe Seylers Z Physiol Chem (1980) 1.45

Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature (1998) 1.43

Molecular epidemiology of beta-lactamase-specifying plasmids of Haemophilus ducreyi. Antimicrob Agents Chemother (1982) 1.41

Effect of mild hypothermia on cerebral oxygen uptake during gradual cerebral perfusion pressure decrease in piglets. Crit Care Med (2000) 1.40

Treatment of benign prostatic hyperplasia by occlusion of the impaired urogenital venous system - first experience. Rofo (2014) 1.39

Determination of immunoreactive trypsin, pancreatic elastase and chymotrypsin in extracts of human feces and ileostomy drainage. Digestion (1983) 1.37

[Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent]. Arzneimittelforschung (1968) 1.36

Health care expenditure in the last months of life. J Health Econ (2000) 1.35

Functional domains of the heavy metal-responsive transcription regulator MTF-1. Nucleic Acids Res (1995) 1.33

Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J Clin Invest (1991) 1.31

Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitor. Biochim Biophys Acta (1982) 1.31

Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study. Lymphology (2002) 1.31

LEKTI, a novel 15-domain type of human serine proteinase inhibitor. J Biol Chem (1999) 1.28

Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor. Scand J Clin Lab Invest (1976) 1.27

Subnormal levels of glucose in urine. A sign of urinary tract infection. JAMA (1967) 1.25

Prevalence of child and adolescent psychiatric disorders: the Zürich Epidemiological Study. Acta Psychiatr Scand (1998) 1.24

Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. Kidney Int (2006) 1.23

Leukocyte activation detected by increased plasma levels of inflammatory mediators in patients with ischemic cerebrovascular diseases. Stroke (1996) 1.22

Human cystatin C. role of the N-terminal segment in the inhibition of human cysteine proteinases and in its inactivation by leucocyte elastase. Biochem J (1991) 1.22

Elimination of 125-I-trypsin alpha-macroglobulin complexes from blood by reticuloendothelial cells in dogs. Acta Physiol Scand (1971) 1.22

Ultrasonic determination of gingival thickness. Subject variation and influence of tooth type and clinical features. J Clin Periodontol (1996) 1.22

[Cross-sectional field 14 pain medicine. Implementation of the German Pain Society (DGSS) core curriculum in the model study course MaReCuM]. Schmerz (2013) 1.21

Refined 1.2 A crystal structure of the complex formed between subtilisin Carlsberg and the inhibitor eglin c. Molecular structure of eglin and its detailed interaction with subtilisin. EMBO J (1986) 1.20

Studies of the release and turnover of a human neutrophil lipocalin. Scand J Clin Lab Invest (1995) 1.20

The isolation and characterization of a family of serine protease genes expressed in activated cytotoxic T lymphocytes. Immunol Rev (1988) 1.20

Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa. J Infect Dis (1986) 1.19

Pretreatment with sufentanil reduces myoclonus after etomidate. Acta Anaesthesiol Scand (2003) 1.17

Dextran sulfate activates contact system and mediates arterial hypotension via B2 kinin receptors. J Appl Physiol (1985) (1994) 1.17

Questionnaire versus direct technical measurements in assessing postures and movements of the head, upper back, arms and hands. Scand J Work Environ Health (2001) 1.14

Demonstration and semiquantitative determination of complexes between various proteases and human alpha2-macroglobulin. Clin Chim Acta (1976) 1.14

Elevated serum levels of pancreatic secretory proteins in cigarette smokers after secretin stimulation. J Clin Invest (1980) 1.14

Isolation and partial characterization of a low molecular weight acid stable protease inhibitor from human bronchial secretion. Hoppe Seylers Z Physiol Chem (1977) 1.13

Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes (2000) 1.13

Neutral proteases of human granulocytes. III. Interaction between human granulocyte elastase and plasma protease inhibitors. Scand J Clin Lab Invest (1974) 1.13

Alpha1-antitrypsin and alpha2-macroglobulin. Interactions with human neutrophil collagenase and elastase. Ann N Y Acad Sci (1975) 1.13

Granulocyte collagenase, elastase and plasma protease inhibitors in purulent sputum. Eur J Clin Invest (1975) 1.13

[On protease inhibitors. I. Isolation and characterization of trypsin inhibitors from dog pancreas tissue and pancreas scretion]. Hoppe Seylers Z Physiol Chem (1966) 1.12

In vivo interaction beween trypsin and some plasma proteins in relation to tolerance to intravenous infusion of trypsin in dog. Acta Chir Scand (1971) 1.12

ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res (2001) 1.11

Quantification of granulocyte elastase inhibitors in human mixed saliva and in pure parotid secretion. Hoppe Seylers Z Physiol Chem (1983) 1.11

Localization of chymotrypsin-like cationic protein, collagenase and elastase in azurophil granules of human neutrophilic polymorphonuclear leukocytes. Hoppe Seylers Z Physiol Chem (1977) 1.10

Distribution of antileukoprotease in upper respiratory mucosa. Ann Otol Rhinol Laryngol (1982) 1.09

Design of a minimal protein oligomerization domain by a structural approach. Protein Sci (2000) 1.09

Effects of granulocyte neutral proteases on complement components. Scand J Immunol (1976) 1.07

Long-term effects of HIV-1 protease inhibitors on insulin secretion and insulin signaling in INS-1 beta cells. J Endocrinol (2004) 1.07

Enhancement of calcium influx in human platelets by CGP 28392, a novel dihydropyridine. Biochem Biophys Res Commun (1984) 1.06

[Ambulatory delivery: organization and experience (author's transl)]. Ther Umsch (1981) 1.06

Neutrophil elastase and secretory leukocyte protease inhibitor in prelabor rupture of membranes, parturition and intra-amniotic infection. J Matern Fetal Neonatal Med (2002) 1.06

The RNA helicase RHAU (DHX36) unwinds a G4-quadruplex in human telomerase RNA and promotes the formation of the P1 helix template boundary. Nucleic Acids Res (2012) 1.05

Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis (1997) 1.05

Studies of ciliated epithelia of the human genital tract. 3: Mucociliary wave activity in organ cultures of human Fallopian tubes challenged with Neisseria gonorrhoeae and gonococcal endotoxin. Br J Vener Dis (1979) 1.05

Release of proteolytic enzymes in bile-induced pancreatitis in dogs. Gastroenterology (1975) 1.04

Human plasma kininogens are identical with alpha-cysteine proteinase inhibitors. Evidence from immunological, enzymological and sequence data. FEBS Lett (1985) 1.04

Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course. Scand J Gastroenterol (1984) 1.04

Comparative study of the teratogenicity of phenobarbitone, diphenylhydantoin and carbamazepine in mice. Toxicology (1977) 1.04

Experimental pancreatitis in the dog. Demonstration of trypsin in ascitic fluid, lymph and plasma. Scand J Gastroenterol (1973) 1.04

Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis. Thromb Res (1986) 1.04

Immunoreactive granulocyte elastase in human serum. Hoppe Seylers Z Physiol Chem (1978) 1.03

Effect of education, occupation and some lifestyle factors on common rheumatic complaints in a Swedish group aged 50-70 years. Ann Rheum Dis (1992) 1.03

Pancreatic endoproteases and pancreatic secretory trypsin inhibitor immunoreactivity in human Paneth cells. J Clin Pathol (1986) 1.03

Vaccination against Staphylococcus aureus mastitis: immunological response of mice vaccinated with fibronectin-binding protein (FnBP-A) to challenge with S. aureus. Vaccine (1994) 1.02

Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study. Exp Clin Endocrinol Diabetes (2004) 1.02

Endo-sponge assisted treatment of anastomotic leakage following colorectal surgery. Colorectal Dis (2009) 1.01

Inflammatory mediators, infection, sepsis, and multiple organ failure after severe trauma. Arch Surg (1992) 1.01

Leukocyte activation: relation to cardiovascular mortality after cerebrovascular ischemia. Cerebrovasc Dis (2000) 1.01

Lack of beta-adrenoreceptor hypersensitivity after abrupt withdrawal of long-term therapy with oxprenolol. Circulation (1981) 1.01

Fish processing work: the impact of two sex dependent exposure profiles on musculoskeletal health. Occup Environ Med (1999) 1.01

Potential diagnostic value of sampling oral mucosal surfaces for Actinobacillus actinomycetemcomitans in young adults. Eur J Oral Sci (1996) 1.01

Released granulocytic elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery. Surgery (1985) 1.00

Self-assessed and directly measured occupational physical activities--influence of musculoskeletal complaints, age and gender. Appl Ergon (2004) 1.00